Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus sufentanil for postoperative acute pain in burn patients
ChiCTR2200058748Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in acute postoperative pain (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: NRS pain score. Started May 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2200058748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058748.